ALPHAPORT.AI
🇹🇼MIKOBEAUTE6574
TWDUSD
SectorHealth CareIndustryBiotechWebsitehttps://www.mikobeaute.com
Management
呂慶盛
CEO

Company information

Ticker
6574
Country
Taiwan
Sector
Health Care
Industry
Biotech

MIKOBEAUTE Business Summary

Mikobeaute International Co., Ltd. (6574.TWO) operates a high-margin integrated beauty model, generating revenue through the wholesale and retail distribution of premium skincare products and service-based fees from its medical-grade spa network. The company manages a multi-brand portfolio tailored to distinct market tiers: EDN (luxury anti-aging), NU+ derma (professional cosmeceuticals), and L'HERBOFLORE (lifestyle masks and aromatherapy). Its business is segmented into product sales via nearly 50 high-end department store counters and personalized aesthetic services at its MIKOBEAUTÉ Spa & Skin Solution centers, which utilize AI 4.0 diagnostics for bespoke treatment plans. In the competitive Taiwanese landscape, Mikobeaute contends with major players such as DR.WU (6523.TWO), Jourdeness (4190.TW), and Natural Beauty (0157.HK), positioning itself as a premium, vertically integrated specialist focused on high-net-worth consumer retention and scientific skincare innovation. The company was founded in 2002 by Ching-Sheng Lu (Sam) and his partner Miko, who scaled the business from a small boutique team into a publicly traded enterprise on the Taipei Exchange. Current leadership is spearheaded by Chairman and General Manager Ching-Sheng Lu, whose pedigree is rooted in brand acquisition and the localized adaptation of international skincare technologies for Asian skin profiles. The executive team is supported by a board featuring independent directors with deep legal and financial expertise, including Kuei-Kuang Lin and Wen-Bin Wu. Notable institutional backing includes Darwin Venture Management, reflecting the company's strategic focus on blending traditional retail excellence with advanced biotechnology and digital health diagnostics.

Financial Metric TrendsQuarterly⌄
Business Overview is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.